A carregar...

Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer

Cyclin-dependent kinase (CDK) inhibitors represent a new form of cytotoxic chemotherapy. Advanced practitioners can read this article to find out about the science behind CDK inhibition, when CDKs are indicated, how to monitor for and manage side effects, as well as when and how to dose adjust.

Na minha lista:
Detalhes bibliográficos
Publicado no:J Adv Pract Oncol
Main Authors: Schwartzberg, Lee S., Greene, Heather R.
Formato: Artigo
Idioma:Inglês
Publicado em: Harborside Press 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6003757/
https://ncbi.nlm.nih.gov/pubmed/29928547
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!